Over 450 Total Lots Up For Auction at Three Locations - CO 05/12, PA 05/15, NY 05/20

Artery Disease Faces Future Enemy in Bioabsorbable Stents

Press releases may be edited for formatting or style | January 30, 2013

*MediPoint: Bioabsorbable Stents - Global Analysis and Market Forecasts

This report offers an overview of coronary and peripheral artery disease, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.It includes annualized bioabsorbable stent market revenue, annual cost of disease and BAS adoption pattern data from 2009-2011 and forecast for seven years to 2018.

stats Advertisement
DOTmed text ad

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

stats

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData's team of industry experts.

For guidelines on how to cite GlobalData, please see http://www.globaldata.com/QuotingGlobalData.aspx.

-ABOUT GLOBALDATA-

GlobalData is a leading global business intelligence provider offering advanced analytics to help clients make better, more informed decisions every day. Our research and analysis is based on the expert knowledge of over 700 qualified business analysts and 25,000 interviews conducted with industry insiders every year, enabling us to offer the most relevant, reliable and actionable strategic business intelligence available for a wide range of industries.

For more information, please contact our Press Office on +44 (0)1204 543 528 or at pr@globaldata.com.

Back to HCB News

You Must Be Logged In To Post A Comment